Insulet had three patents in future of work during Q2 2024. The patent filed by Insulet Corp in Q2 2024 describes a method to terminate the application of an electric pulse to a shape memory alloy (SMA) element in a medicament pump. This method is based on resistance values, including magnitude, rate of change, temperature, time elapsed, or combinations thereof, rather than mechanical mechanisms. Monitoring the resistance of an unactuated SMA element is used to determine when to initiate and terminate the application of the electric pulse to another SMA element. GlobalData’s report on Insulet gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Insulet had no grants in future of work as a theme in Q2 2024.
Recent Patents
Application: Use of one or more metrics to trigger electric pulse initiation and/or termination during control of actuation of a medicament delivery pump (Patent ID: US20240136135A1)
The patent filed by Insulet Corp. describes a medicament delivery device that utilizes a shape memory alloy (SMA) element to actuate a medicament pump. Unlike conventional methods that rely on mechanical triggers, this device uses resistance values to determine when to terminate the application of an electric pulse to the SMA element. The termination can be triggered based on factors such as resistance magnitude, rate of change of resistance, temperature of the SMA element, time elapsed since the pulse was initiated, or a combination of these factors.
The device's processor is responsible for monitoring the resistance of the SMA element over time and making decisions regarding the termination of the electric pulse based on this data. The processor can calculate resistance values from collected voltage and current readings, determine moving average values, analyze derivatives of resistance values, and compare these metrics to predefined thresholds to decide when to terminate the pulse. Additionally, the device can incorporate temperature sensing and time tracking to further refine the termination decision-making process. This innovative approach to controlling the actuation of the medicament pump offers a more precise and efficient method compared to traditional mechanical triggers, enhancing the overall functionality and reliability of the medicament delivery device.
To know more about GlobalData’s detailed insights on Insulet, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.